Authors:
Shirahata, A
Kamiya, T
Takamatsu, J
Kojima, T
Fukutake, K
Arai, M
Hanabusa, H
Tagami, H
Yoshioka, A
Shima, M
Naka, H
Fujita, S
Minamoto, Y
Kamizono, J
Saito, H
Citation: A. Shirahata et al., Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitors, INT J HEMAT, 73(4), 2001, pp. 517-525
Authors:
Shimizu, S
Katano, H
Sata, T
Chen, KR
Tagami, H
Hanabusa, H
Shimizu, H
Citation: S. Shimizu et al., Absence of anti-human herpesvirus 8 antibody in 32 Japanese hemophiliacs with advanced HIV infection, ARCH DERM R, 293(7), 2001, pp. 380-381
Authors:
He, LM
Terunuma, H
Hanabusa, H
Iwamoto, A
Oka, S
Tanabe, F
Chiba, N
Kurimoto, M
Ikeda, M
Okamura, H
Dai, JH
Iwatani, Y
Ishida, T
Ito, M
Citation: Lm. He et al., Interleukin 18 and interleukin 1 beta production is decreased in HIV type 1-seropositive hemophiliacs but not in HIV type 1-seropositive nonhemophiliacs, AIDS RES H, 16(4), 2000, pp. 345-353
Authors:
Fujiwara, A
Ishii, K
Watanuki, T
Suematsu, H
Nakao, H
Ohwada, K
Fujii, Y
Murakami, Y
Mori, T
Kawada, H
Kikegawa, T
Shimomura, O
Matsubara, T
Hanabusa, H
Daicho, S
Kitamura, S
Katayama, C
Citation: A. Fujiwara et al., Synchrotron radiation X-ray powder diffractometer with a cylindrical imaging plate, J APPL CRYS, 33, 2000, pp. 1241-1245
Citation: H. Hanabusa, Renal atrophy associated with long-term treatment with indinavir (vol 340,pg 392, 1999), N ENG J MED, 340(12), 1999, pp. 976-976